Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Pharmaceutical Statistics|April 13, 2019
Equilibrium, affinity, dissociation constants, IC5O: Facts and fantasiesJacques Barbet, Sandrine Huclier-MarkaiCurrent Radiopharmaceuticals|December 29, 2011
The ARRONAX projectFerid Haddad, Jacques Barbet, Jean-Francois ChatalAnalytical Biochemistry|November 5, 2002
Equilibrium expert: an add-in to Microsoft Excel for multiple binding equilibrium simulations and parameter estimationsOlivier Raguin, Anne Gruaz-Guyon, Jacques BarbetMedecine Sciences : M/S|December 29, 2009
[Radiolabeled antibodies for cancer treatment]Jacques Barbet, Jean-François Chatal, Françoise Kraeber-BodéréEJNMMI Research|April 9, 2013
Calculating an estimate of tissue integrated activity in 18F-FDG PET imaging using one SUV valueEric Laffon, Manuel Bardiès, Jacques Barbet, et al.Cancer Biotherapy & Radiopharmaceuticals|January 6, 2011
Kinetic model analysis for absorbed dose calculation applied to brain in [¹⁸F]-fluorodeoxyglucose positron emission tomography imagingEric Laffon, Manuel Bardiès, Jacques Barbet, et al.Cancer Biotherapy & Radiopharmaceuticals|September 6, 2008
What can be expected from nuclear medicine tomorrow?Jacques Barbet, Françoise Kraeber-Bodéré, Jean-François ChatalJournal of Cancer Research and Therapeutics|December 17, 2009
Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumorsJean-Francois Chatal, Francois Davodeau, Michel Cherel, et al.International Journal of Cancer|July 13, 2002
Pharmacokinetic and tumor-seeking properties of recombinant and nonrecombinant anti-carcinoembryonic antigen antibody fragmentsAgnès Groulet, Mylène Dorvillius, André Pèlegrin, et al.The Journal of Clinical Endocrinology and Metabolism|August 11, 2005
Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinomaJacques Barbet, Loïc Campion, Françoise Kraeber-Bodéré, et al.Pageof 9